MMP9 and cancer: In conclusion, this study suggests pKAL exhibits anti-cancer effects on RT-R-MDA-MB-231 cells, by suppressing CD44 and Oct 3/4, β-catenin and MMP-9 which appeared to be linked to the RT resistance of RT-R-MDA-MB-231 cells.